IFNG and neoplasm: We previously demonstrated that tumor-specific type-1 T cells, which predominantly secrete IFN-γ, can efficiently traffic into CNS tumors and mediate effective therapeutic efficacy via type-1 chemokine CXCL10 (17, 18).